Shares of Endo Pharmaceuticals Holdings rocketed 23% on Tuesday to close at $24.53 on news that the company had won its appeal to market its generic OxyContin products.
*For more on this story,
read the full MarketWatch article.
Endo Pharma Wins Appeal
Want more from the best local business newspaper in the country?
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
Would you like to subscribe to Orange County Business Journal?
One-Year for Only $99
- Unlimited access to OCBJ.com
- Daily OCBJ Updates delivered via email each weekday morning
- Journal issues in both print and digital format
- The annual Book of Lists: industry of Orange County's leading companies
- Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!
